Log In
Print
BCIQ
Print
Print this Print this
 

3C23K

  Manage Alerts
Collapse Summary General Information
Company LFB S.A.
DescriptionMAb targeting anti-Mullerian hormone receptor type II (AMHR2)
Molecular Target Anti-Mullerian hormone receptor type II (AMHR2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

Partner

GamaMabs Pharma S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today